PL82632B1 - - Google Patents
Download PDFInfo
- Publication number
- PL82632B1 PL82632B1 PL1972158524A PL15852472A PL82632B1 PL 82632 B1 PL82632 B1 PL 82632B1 PL 1972158524 A PL1972158524 A PL 1972158524A PL 15852472 A PL15852472 A PL 15852472A PL 82632 B1 PL82632 B1 PL 82632B1
- Authority
- PL
- Poland
- Prior art keywords
- formula
- nitro
- group
- pyridazine
- triazolo
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 17
- 150000003839 salts Chemical class 0.000 claims description 7
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 125000003277 amino group Chemical group 0.000 claims description 3
- IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical compound NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- JIZRGGUCOQKGQD-UHFFFAOYSA-N 2-nitrothiophene Chemical class [O-][N+](=O)C1=CC=CS1 JIZRGGUCOQKGQD-UHFFFAOYSA-N 0.000 claims description 2
- CBHTTYDJRXOHHL-UHFFFAOYSA-N 2h-triazolo[4,5-c]pyridazine Chemical group N1=NC=CC2=C1N=NN2 CBHTTYDJRXOHHL-UHFFFAOYSA-N 0.000 claims description 2
- 125000005122 aminoalkylamino group Chemical group 0.000 claims description 2
- 125000006310 cycloalkyl amino group Chemical group 0.000 claims description 2
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 2
- 229960001907 nitrofurazone Drugs 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 125000004193 piperazinyl group Chemical group 0.000 claims description 2
- 229910052717 sulfur Chemical group 0.000 claims description 2
- VLLMWSRANPNYQX-UHFFFAOYSA-N thiadiazole Chemical compound C1=CSN=N1.C1=CSN=N1 VLLMWSRANPNYQX-UHFFFAOYSA-N 0.000 claims description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 239000011593 sulfur Chemical group 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- -1 stearic acid) Chemical class 0.000 description 24
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 20
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 17
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 12
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 10
- 238000002844 melting Methods 0.000 description 10
- 230000008018 melting Effects 0.000 description 10
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- 239000000047 product Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- TYAWSMIEHCWBRF-UHFFFAOYSA-N 6-(aminomethylidene)-3-(5-nitrofuran-2-yl)-5H-[1,2,4]triazolo[4,3-b]pyridazin-7-amine Chemical compound C1=C(N)C(=CN)NN2C1=NN=C2C1=CC=C([N+]([O-])=O)O1 TYAWSMIEHCWBRF-UHFFFAOYSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- WRMORXSQCVEYOM-UHFFFAOYSA-N [1,2,4]triazolo[4,3-b]pyridazin-3-amine Chemical compound C1=CC=NN2C(N)=NN=C21 WRMORXSQCVEYOM-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 150000007514 bases Chemical group 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- JUOXYWXXPHUSAI-UHFFFAOYSA-N ethylamino acetate Chemical compound CCNOC(C)=O JUOXYWXXPHUSAI-UHFFFAOYSA-N 0.000 description 2
- 150000007857 hydrazones Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- VLXSIHLNPYRFFN-UHFFFAOYSA-N 1,4-dioxane;methanol Chemical compound OC.C1COCCO1 VLXSIHLNPYRFFN-UHFFFAOYSA-N 0.000 description 1
- AFXZJIQBEQYERW-UHFFFAOYSA-N 1-(4-methylpiperazin-1-yl)-n-[3-(5-nitrofuran-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]methanimine Chemical compound C1CN(C)CCN1C=NC1=NN2C(C=3OC(=CC=3)[N+]([O-])=O)=NN=C2C=C1 AFXZJIQBEQYERW-UHFFFAOYSA-N 0.000 description 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- YTQQIHUQLOZOJI-UHFFFAOYSA-N 2,3-dihydro-1,2-thiazole Chemical compound C1NSC=C1 YTQQIHUQLOZOJI-UHFFFAOYSA-N 0.000 description 1
- KYBLUOVPGCYJIE-UHFFFAOYSA-N 3-(5-nitrothiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine Chemical compound N12N=C(N)C=CC2=NN=C1C1=CC=C([N+]([O-])=O)S1 KYBLUOVPGCYJIE-UHFFFAOYSA-N 0.000 description 1
- GESDVHWGYCSIPR-UHFFFAOYSA-N 5-nitrofuran-2-carboximidamide;hydrochloride Chemical compound Cl.NC(=N)C1=CC=C([N+]([O-])=O)O1 GESDVHWGYCSIPR-UHFFFAOYSA-N 0.000 description 1
- PYPILDOACQXJKC-UHFFFAOYSA-N 6-(dimethylaminomethylidene)-3-(5-nitrothiophen-2-yl)-5h-[1,2,4]triazolo[4,3-b]pyridazin-7-amine Chemical compound C1=C(N)C(=CN(C)C)NN2C1=NN=C2C1=CC=C([N+]([O-])=O)S1 PYPILDOACQXJKC-UHFFFAOYSA-N 0.000 description 1
- MQSMYBXHPLDDEQ-UHFFFAOYSA-N 6-(ethoxymethylidene)-3-(5-nitrofuran-2-yl)-5h-[1,2,4]triazolo[4,3-b]pyridazin-7-amine Chemical compound C1=C(N)C(=COCC)NN2C1=NN=C2C1=CC=C([N+]([O-])=O)O1 MQSMYBXHPLDDEQ-UHFFFAOYSA-N 0.000 description 1
- ZXBINOGEDGCQPR-UHFFFAOYSA-N 6-[(cyclohexylamino)methylidene]-3-(5-nitrofuran-2-yl)-5H-[1,2,4]triazolo[4,3-b]pyridazin-7-amine Chemical compound [N+](=O)([O-])C1=CC=C(O1)C1=NN=C2N1NC(C(=C2)N)=CNC2CCCCC2 ZXBINOGEDGCQPR-UHFFFAOYSA-N 0.000 description 1
- DBROFCFDGIQJSR-UHFFFAOYSA-N 6-chloro-3-(5-nitrothiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound S1C([N+](=O)[O-])=CC=C1C1=NN=C2N1N=C(Cl)C=C2 DBROFCFDGIQJSR-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- GSWOYECYOZSRKY-UHFFFAOYSA-N CCOC=C1NN2C(C3=CC=C([N+]([O-])=O)S3)=NN=C2C=C1N Chemical compound CCOC=C1NN2C(C3=CC=C([N+]([O-])=O)S3)=NN=C2C=C1N GSWOYECYOZSRKY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 239000004097 EU approved flavor enhancer Substances 0.000 description 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Natural products CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- SUAKHGWARZSWIH-UHFFFAOYSA-N N,N‐diethylformamide Chemical compound CCN(CC)C=O SUAKHGWARZSWIH-UHFFFAOYSA-N 0.000 description 1
- NQRYJNQNLNOLGT-UHFFFAOYSA-O Piperidinium(1+) Chemical compound C1CC[NH2+]CC1 NQRYJNQNLNOLGT-UHFFFAOYSA-O 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000026723 Urinary tract disease Diseases 0.000 description 1
- 208000012931 Urologic disease Diseases 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000004442 acylamino group Chemical group 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229940027988 antiseptic and disinfectant nitrofuran derivative Drugs 0.000 description 1
- LZLOFGMGFADIKQ-UHFFFAOYSA-N benzene;1,4-dioxane Chemical compound C1COCCO1.C1=CC=CC=C1 LZLOFGMGFADIKQ-UHFFFAOYSA-N 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 125000004181 carboxyalkyl group Chemical group 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- QLZJCVHFVOWABB-UHFFFAOYSA-N ethyl 2-[[7-amino-3-(5-nitrofuran-2-yl)-5H-[1,2,4]triazolo[4,3-b]pyridazin-6-ylidene]methylamino]acetate Chemical compound C1=C(N)C(=CNCC(=O)OCC)NN2C1=NN=C2C1=CC=C([N+]([O-])=O)O1 QLZJCVHFVOWABB-UHFFFAOYSA-N 0.000 description 1
- DQSODFRRQALXRD-UHFFFAOYSA-N ethyl n-[3-(5-nitrofuran-2-yl)-1,2,4-thiadiazol-5-yl]methanimidate Chemical compound S1C(N=COCC)=NC(C=2OC(=CC=2)[N+]([O-])=O)=N1 DQSODFRRQALXRD-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000019264 food flavour enhancer Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229920006158 high molecular weight polymer Polymers 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940046892 lead acetate Drugs 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- HAMGRBXTJNITHG-UHFFFAOYSA-N methyl isocyanate Chemical compound CN=C=O HAMGRBXTJNITHG-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- DAKZISABEDGGSV-UHFFFAOYSA-N n-(2-aminoethyl)acetamide Chemical compound CC(=O)NCCN DAKZISABEDGGSV-UHFFFAOYSA-N 0.000 description 1
- IKMISPPGIXFSGM-UHFFFAOYSA-N n-(ethoxymethyl)-3-(5-nitrofuran-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine Chemical compound N12N=C(NCOCC)C=CC2=NN=C1C1=CC=C([N+]([O-])=O)O1 IKMISPPGIXFSGM-UHFFFAOYSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002905 orthoesters Chemical class 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- HDOWRFHMPULYOA-UHFFFAOYSA-N piperidin-4-ol Chemical compound OC1CCNCC1 HDOWRFHMPULYOA-UHFFFAOYSA-N 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- ZCPSWAFANXCCOT-UHFFFAOYSA-N trichloromethanesulfonyl chloride Chemical compound ClC(Cl)(Cl)S(Cl)(=O)=O ZCPSWAFANXCCOT-UHFFFAOYSA-N 0.000 description 1
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 1
- 208000014001 urinary system disease Diseases 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2153902A DE2153902A1 (de) | 1971-10-29 | 1971-10-29 | Antimikrobiell wirksame nitrofuranderivate und verfahren zur herstellung derselben |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL82632B1 true PL82632B1 (enrdf_load_stackoverflow) | 1975-10-31 |
Family
ID=5823698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1972158524A PL82632B1 (enrdf_load_stackoverflow) | 1971-10-29 | 1972-10-28 |
Country Status (15)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2222834A1 (de) * | 1972-05-10 | 1973-11-29 | Boehringer Mannheim Gmbh | Nitrofuryl-amidin-derivate und verfahren zur herstellung derselben |
| MXPA05006478A (es) * | 2002-12-18 | 2005-09-08 | Vertex Pharma | Triazolopiridazinas como inhibidores de proteinas cinasas. |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1527537A (fr) * | 1966-06-18 | 1968-05-31 | Boehringer & Soehne Gmbh | Procédé de préparation de nouveaux dérivés du 5-nitrofurane et du 5-nitrothiophène |
-
1971
- 1971-10-29 DE DE2153902A patent/DE2153902A1/de active Pending
-
1972
- 1972-10-22 IL IL40639A patent/IL40639A0/xx unknown
- 1972-10-23 ZA ZA727504A patent/ZA727504B/xx unknown
- 1972-10-23 DD DD166425A patent/DD102387A5/xx unknown
- 1972-10-24 GB GB4893772A patent/GB1348088A/en not_active Expired
- 1972-10-24 ES ES407933A patent/ES407933A2/es not_active Expired
- 1972-10-25 AR AR244808A patent/AR197008A1/es active
- 1972-10-27 AT AT917072A patent/AT320628B/de not_active IP Right Cessation
- 1972-10-27 NL NL7214621A patent/NL7214621A/xx unknown
- 1972-10-27 AU AU48277/72A patent/AU467712B2/en not_active Expired
- 1972-10-27 FR FR7238198A patent/FR2158313B2/fr not_active Expired
- 1972-10-27 AT AT61774*A patent/ATA61774A/de not_active IP Right Cessation
- 1972-10-27 AT AT61874*A patent/ATA61874A/de not_active IP Right Cessation
- 1972-10-27 AT AT61774*7A patent/AT327882B/de not_active IP Right Cessation
- 1972-10-27 AT AT61874*7A patent/AT327883B/de not_active IP Right Cessation
- 1972-10-27 HU HUBO1401A patent/HU164715B/hu unknown
- 1972-10-28 PL PL1972158524A patent/PL82632B1/pl unknown
- 1972-10-30 JP JP47108772A patent/JPS4852769A/ja active Pending
-
1973
- 1973-07-30 AR AR249345A patent/AR197054A1/es active
- 1973-07-30 AR AR249346A patent/AR197055A1/es active
-
1974
- 1974-04-19 SU SU2018982A patent/SU511006A3/ru active
- 1974-04-19 SU SU2018983A patent/SU509235A3/ru active
Also Published As
| Publication number | Publication date |
|---|---|
| FR2158313B2 (enrdf_load_stackoverflow) | 1976-04-23 |
| ATA61874A (de) | 1975-05-15 |
| SU511006A3 (ru) | 1976-04-15 |
| DD102387A5 (enrdf_load_stackoverflow) | 1973-12-12 |
| IL40639A0 (en) | 1972-12-29 |
| AT327882B (de) | 1976-02-25 |
| AR197054A1 (es) | 1974-03-08 |
| AT320628B (de) | 1975-02-25 |
| HU164715B (enrdf_load_stackoverflow) | 1974-04-11 |
| JPS4852769A (enrdf_load_stackoverflow) | 1973-07-24 |
| AT327883B (de) | 1976-02-25 |
| AU467712B2 (en) | 1975-12-11 |
| AU4827772A (en) | 1974-05-16 |
| ES407933A2 (es) | 1975-11-01 |
| ZA727504B (en) | 1973-08-29 |
| DE2153902A1 (de) | 1973-05-03 |
| GB1348088A (en) | 1974-03-13 |
| ATA61774A (de) | 1975-05-15 |
| FR2158313A2 (enrdf_load_stackoverflow) | 1973-06-15 |
| AR197008A1 (es) | 1974-03-08 |
| AR197055A1 (es) | 1974-03-08 |
| SU509235A3 (ru) | 1976-03-30 |
| NL7214621A (enrdf_load_stackoverflow) | 1973-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69430988T2 (de) | Pyrazolotriazine mit interleukin-1 und tumor necrosis faktor inhibitor wirkung | |
| JP5258790B2 (ja) | Ｒｈｏキナーゼインヒビター | |
| US4621084A (en) | Imidazo-heterocyclic compounds and pharmaceutical composition comprising the same | |
| US4904666A (en) | Pyrazolo(3,4-d)pyrimidine compounds, compositions and method of use | |
| PL184093B1 (pl) | Nowe związki pirydo [ 2,3-d] pirymidynowe i kompozycje je zawierające | |
| EP2172469A1 (en) | Diazabicyclic aryl derivatives as cholinergic receptor modulators | |
| CA2471265C (en) | Pyrimidotriazines as phosphatase inhibitors | |
| US4824848A (en) | Pyrazolo[3,4-d]pyrimidine derivatives, their production and use | |
| EP0500136B1 (en) | 1,2,4-Triazolo[1,5-a]pyrimidine derivatives, a process for preparing them as well as medicaments containing them and the use of them | |
| US4686227A (en) | Imidazoisoquinoline compounds useful as anti-ulcerative agents | |
| PT95317A (pt) | Processo para a obtencao de um novo composto tiazol destinado | |
| US20060205740A1 (en) | Chemical compounds | |
| US4528288A (en) | Substituted triazolo[1,5-c]pyrimidines | |
| PL82632B1 (enrdf_load_stackoverflow) | ||
| CS262417B2 (en) | Process for preparing new 1h,3h-pyrrolo/1,2-c/-thiazoles | |
| US5276028A (en) | Imidazoquinoxaline compounds | |
| US2748124A (en) | 1-(4-anilino-2-pyrimidino)-3-alkylureas | |
| US4705787A (en) | Quinazolinone derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same | |
| HU206095B (en) | Process for producing triazolylcarboxylc acid hydrazie and semicarbazide derivatives and pharmaceutical compositions comprising same | |
| EP0535104B1 (en) | Heterocyclic compounds and their preparation and use | |
| JP3162727B2 (ja) | 複素環式化合物並びにそれらの製造および使用 | |
| EP0369743A2 (en) | Heterocyclic amides | |
| US20090143375A1 (en) | Tricyclic Lactam Derivatives, Their Manufacture and Use as Pharmaceutical Agents | |
| US4478835A (en) | Substituted imidazo[1,5-c]pyrimidines | |
| PL84022B1 (enrdf_load_stackoverflow) |